Work

Abstract 839: The clinical C/EBPβ antagonist peptide lucicebtide synergizes with molecularly targeted therapies in GBM

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-839

Authors: Julia Diehl, Ricardo Ramirez, Mark Koester, Franco Abbate, Lila Ghamsari, Abi Vainstein-Haras, Barry J. Kappel, Claudio Scuoppo, Jim A. Rotolo

Institution: Sapience Therapeutics

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409625876

Cites:

Cited by:

Related to: 10